Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells

被引:25
作者
Sheriff, S
Dautzenberg, FM
Mulchahey, JJ
Pisarka, M
Hauger, RL
Chance, WT
Balasubramanian, A
Kasckow, JW
机构
[1] Vet Adm Med Ctr, Psychiat Serv 116A, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA
[3] Axovan LTD, Innovat Ctr, CH-4123 Allschwil, Switzerland
[4] Univ Cincinnati, Sch Med, Dept Psychiat, Cincinnati, OH 45267 USA
[5] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92092 USA
[6] VA Med Ctr, La Jolla, CA 92092 USA
[7] Univ Cincinnati, Program Neurosci, Cincinnati, OH 45267 USA
关键词
amygdala; corticotropin-releasing factor; neuropeptide Y; cAMP;
D O I
10.1016/S0196-9781(01)00549-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Corticotropin-releasing factor (CRF) is a 41 amino acid neuropeptide which is involved in the stress response. CRF and neuropeptide Y (NPY) produce reciprocal effects on anxiety in the central nucleus of the amygdala. The molecular mechanisms of possible CRF-NPY interactions in regulating anxiety behavior is not known. In the central nervous system, the action of NPY leads to inhibition of cAMP production while CRF is known to stimulate levels of cAMP in the brain. Consequently, we hypothesized that NPY may antagonize anxiety-like behavior by counter-regulating CRF-stimulated cAMP accumulation and activation of the protein kinase A pathway. We have engineered an immortalized amygdalar cell line (AR-5 cells) which express via RT-PCR, the CRF2alpha, Y-1 and Y5NPY receptor. In addition, in these cells CRF treatment results in significant concentration-dependent increases in cAMP production. Furthermore, incubation of 3 muM CRF with increasing concentrations of NPY was able to significantly inhibit the increases in cAMP compared to that observed with 3 muM CRF treatment alone. These findings suggest that CRF and NPY may counter-regulate each other in amygdalar neurons via reciprocal effects on the protein kinase A pathway. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2083 / 2089
页数:7
相关论文
共 44 条
[41]   MODULATION OF ANXIETY AND NEUROPEPTIDE-Y-Y1 RECEPTORS BY ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
WAHLESTEDT, C ;
PICH, EM ;
KOOB, GF ;
YEE, F ;
HEILIG, M .
SCIENCE, 1993, 259 (5094) :528-531
[42]   NEUROPEPTIDE-Y RECEPTOR SUBTYPES [J].
WAN, CP ;
LAU, BHS .
LIFE SCIENCES, 1995, 56 (13) :1055-1064
[43]   A NEURON-SPECIFIC ENHANCER TARGETS EXPRESSION OF THE GONADOTROPIN-RELEASING-HORMONE GENE TO HYPOTHALAMIC NEUROSECRETORY NEURONS [J].
WHYTE, DB ;
LAWSON, MA ;
BELSHAM, DD ;
ERALY, SA ;
BOND, CT ;
ADELMAN, JP ;
MELLON, PL .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (04) :467-477
[44]  
Yamada K, 1996, BRAIN RES, V725, P272, DOI 10.1016/0006-8993(96)00405-2